Endocrine Abstracts

Background: Mortality and morbidity after acute myocardial infarction (AMI) remain high even when myocardial reperfusion is successful. Thus, additional approaches are warranted. Erythropoietin (EPO) was found to be a cytoprotective molecule that might represent a novel strategy to limit the infarct size.Aim of the work: To investigate serum erythropoietin level and its relation to infarct size in Egyptian patients with AMI.Methods...